Reuters logo
BRIEF-Mabion to get 28 mln zloty subsidy for biotech medicine development
October 5, 2017 / 7:58 AM / 16 days ago

BRIEF-Mabion to get 28 mln zloty subsidy for biotech medicine development

Oct 5 (Reuters) - MABION SA:

* SAID ON WEDNESDAY THAT NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT IN POLAND HAS SIGNED THE CONTRACT TO FINANCE THE COMPANY‘S PROJECT FOR DEVELOPMENT OF A BIOTECH MEDICINE

* THE SUBJECT OF THE PROJECT IS TO CARRY OUT R&D WORKS AIMED AT DEVELOPING MABIONEGFR - MONOCLONAL ANTIBODY WITH THE POTENTIAL OF THE MEDICINAL PRODUCT FOR USE IN ONCOLOGIC INDICATIONS

* THE TOTAL VALUE OF THE PROJECT AMOUNTS TO 40 MILLION ZLOTYS AND THE SUBSIDY VALUE AMOUNTS TO 28 MILLION ZLOTYS

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below